3,7-dimethyloct-6-en-3-ol is a monoterpene.
Definition
US FDA substance register · UNII VW0O7I863L · registered name 3,7-DIMETHYLOCT-6-EN-3-OL · single chemical substance
3,7-dimethyloct-6-en-3-ol is a monoterpene.
Source: PubChem
Cosmetic roles
Safety & regulatory references
Not classified under Korea’s toxic-substance GHS list · existing chemical substance
More data — names, identifiers, properties, test records, literature
Names & identifiers
- CAS No.chemical registry number
- 18479-51-1
- EC No.EU chemical inventory number
- 242-359-8
- DTXSIDUS EPA chemical ID
- DTXSID1044809
- DTXCIDUS EPA compound ID
- DTXCID9024809
- IUPAC
- 3,7-Dimethyloct-6-en-3-ol
- Molecular formula
- C10H20O
- Molecular weight
- 156.269 g/mol
Measured properties
- Appearance
- Dry Powder, Liquid · liquid
- Initial boiling point and range
- 202.89 ℃
- Flash point
- 86 ℃
- Vapour pressure
- 0.07
- Water solubility
- 1.27 g/100g (19.5 °C, pH:7.9-8)
- Relative density
- 0.853g/cm³
- n-Octanol/water partition coefficient (Kow)
- 2.9
- Auto-ignition temperature
- 293 ℃
- Molecular weight
- 156.267
Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.
Source: PubChem · KOSHA safety data sheets (Korea)
What products actually use it for
What the 10 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Fragrance9
- Flavouring and nutrient1
Source: US EPA CompTox dashboard
Irritation and sensitisation studies
5 skin studies and 0 eye studies are on record.
The studies disagree (the most common conclusion covers 25%), so they do not establish that this ingredient is irritating. These tests are on the raw material itself; irritation at the amount in a finished product is a different question.
See all 5 studies
- Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) updated 06 July 2012 - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · equivalent or similar to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) - Ambiguous
skin sensitisation: in vivo (LLNA) · Screening · equivalent or similar to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Source: US EPA CompTox dashboard
Linked databases 14
- Australian Industrial Chemicals Inventory (AICIS)
- ChEBI
- ChEMBL
- EU CosIng ingredient list 2
- Korea toxic substances GHS register (NIER)
- KOSHA safety data sheets (Korea)
- NIST Chemistry WebBook
- PubChem 2
- UniChem cross-reference IDs
- US EPA CompTox dashboard 2
- US EPA DSSTox chemical database
- US FDA substance registration (GSRS)
- US FDA Unique Ingredient Identifier (UNII)
- Wikidata